IGEA worldwide

IGEA has two main areas of interest:
- Orthopaedics, for the treatment of traumatic bone diseases and cartilage lesions.
- Oncology, for the treatment of solid tumors with electrochemotherapy.

With regards to Oncology, IGEA is actively involved with more than 150 specialist centres in Europe using the electrochemotherapy by means of the Cliniporator® technology. 

More than 600 scientific articles have been published of which 300 reported clinical activity which confirmed the efficacy and safety of electrochemotherapy when applied with the Cliniporator® technology.

Over the years, IGEA has favored the creation of a wide network of international scientific relationships which has led to a fruitful research activities as well astreating a large number of international patents.

IGEA's activities has now extended to 18 European countries, 6 non-european countries and the USA (currently limited to veterinary use) and is also located with its own offices in Germany and the United Kingdom.

The contents of this website is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice because of something you have read on this website.
This website does not recommend or endorse any specific tests, physicians, medical products, procedures, opinions, or other information that may be mentioned on the Site.
The site and its contents are provided on an "as is" basis by the public communication department of IGEA S.p.A.

IGEA © 2019